Amoeba SA (ALMIB) - Net Assets
Based on the latest financial reports, Amoeba SA (ALMIB) has net assets worth €-5.36 Million EUR (≈ $-6.27 Million USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€10.13 Million ≈ $11.85 Million USD) and total liabilities (€15.49 Million ≈ $18.11 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Amoeba SA PP&E and investment ratio to assess the company's strategic physical and investment asset allocation.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €-5.36 Million |
| % of Total Assets | -52.91% |
| Annual Growth Rate | N/A |
| 5-Year Change | -2798.38% |
| 10-Year Change | -28883.04% |
| Growth Volatility | 21494.12 |
Amoeba SA - Net Assets Trend (2011–2025)
This chart illustrates how Amoeba SA's net assets have evolved over time, based on quarterly financial data. For live market cap and overall valuation, see Amoeba SA market cap and net worth.
Annual Net Assets for Amoeba SA (2011–2025)
The table below shows the annual net assets of Amoeba SA from 2011 to 2025. Also explore ALMIB year-over-year net asset growth to track the company's year-over-year net asset growth rate.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | €-5.36 Million ≈ $-6.27 Million |
+48.50% |
| 2024-12-31 | €-10.41 Million ≈ $-12.17 Million |
-163.94% |
| 2023-12-31 | €-3.94 Million ≈ $-4.61 Million |
-148.31% |
| 2022-12-31 | €8.16 Million ≈ $9.54 Million |
+4008.99% |
| 2021-12-31 | €198.68K ≈ $232.28K |
-90.07% |
| 2020-12-31 | €2.00 Million ≈ $2.34 Million |
-52.68% |
| 2019-12-31 | €4.23 Million ≈ $4.94 Million |
+78041.99% |
| 2018-12-31 | €5.41K ≈ $6.33K |
-56.79% |
| 2017-12-31 | €12.52K ≈ $14.64K |
-32.78% |
| 2016-12-31 | €18.63K ≈ $21.78K |
+75.75% |
| 2015-12-31 | €10.60K ≈ $12.39K |
-99.62% |
| 2014-12-31 | €2.80 Million ≈ $3.27 Million |
+544.95% |
| 2013-12-31 | €433.99K ≈ $507.38K |
-54.18% |
| 2012-12-31 | €947.20K ≈ $1.11 Million |
+58.55% |
| 2011-12-31 | €597.42K ≈ $698.44K |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Amoeba SA's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 793982700.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | €1.38 Million | % |
| Other Comprehensive Income | €-24.20 Million | % |
| Other Components | €25.76 Million | % |
| Total Equity | €-5.36 Million | 100.00% |
Amoeba SA Competitors by Market Cap
The table below lists competitors of Amoeba SA ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Steady Safe TBK PT
JK:SAFE
|
$45.47 Million |
|
Cofix Group Ltd
TA:CFX
|
$45.48 Million |
|
JD Sports Fashion PLC
LSE:JD
|
$45.49 Million |
|
Indo Acidatama Tbk
JK:SRSN
|
$45.50 Million |
|
Defense Metals Corp
V:DEFN
|
$45.46 Million |
|
Optipharm.CO.LTD
KQ:153710
|
$45.43 Million |
|
Mondi PLC
LSE:MNDI
|
$45.43 Million |
|
Kairous Acquisition Corp Ltd
NASDAQ:KACL
|
$45.42 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Amoeba SA's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from -10,410,083 to -5,361,255, a change of 5,048,828.
- Net loss of 8,303,000 reduced equity.
- Share repurchases of 12,002,110 reduced equity.
- New share issuances of 8,025,910 increased equity.
- Other comprehensive income decreased equity by 6,265,930.
- Other factors increased equity by 23,593,958.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €-8.30 Million | -154.87% |
| Share Repurchases | €12.00 Million | -223.87% |
| Share Issuances | €8.03 Million | +149.7% |
| Other Comprehensive Income | €-6.27 Million | -116.87% |
| Other Changes | €23.59 Million | +440.08% |
| Total Change | €- | % |
Book Value vs Market Value Analysis
This analysis compares Amoeba SA's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2012-12-31 | €0.25 | €0.50 | x |
| 2013-12-31 | €0.12 | €0.50 | x |
| 2014-12-31 | €0.74 | €0.50 | x |
| 2015-12-31 | €2.36 | €0.50 | x |
| 2016-12-31 | €3.23 | €0.50 | x |
| 2017-12-31 | €2.09 | €0.50 | x |
| 2018-12-31 | €0.90 | €0.50 | x |
| 2019-12-31 | €0.54 | €0.50 | x |
| 2020-12-31 | €0.12 | €0.50 | x |
| 2021-12-31 | €0.01 | €0.50 | x |
| 2022-12-31 | €0.24 | €0.50 | x |
| 2023-12-31 | €-0.08 | €0.50 | x |
| 2024-12-31 | €-0.21 | €0.50 | x |
| 2025-12-31 | €-0.08 | €0.50 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Amoeba SA utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 0.00%
- • Asset Turnover: 0.00x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is above the historical average (-360.37%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2012 | -26.07% | -302.90% | 0.05x | 1.81x | €-341.64K |
| 2013 | -120.07% | -172.43% | 0.14x | 5.15x | €-564.49K |
| 2014 | -34.82% | -438.07% | 0.04x | 1.98x | €-1.25 Million |
| 2015 | -37.92% | -2851.48% | 0.01x | 1.33x | €-5.08K |
| 2016 | -30.96% | -4579.41% | 0.01x | 1.25x | €-7.63K |
| 2017 | -49.79% | -3865.77% | 0.01x | 1.72x | €-7.49K |
| 2018 | -133.48% | -5906.85% | 0.01x | 2.57x | €-7.76K |
| 2019 | -171.48% | -5919.10% | 0.01x | 3.27x | €-7.67 Million |
| 2020 | -407.76% | 0.00% | 0.00x | 6.53x | €-8.36 Million |
| 2021 | -3934.54% | 0.00% | 0.00x | 72.99x | €-7.84 Million |
| 2022 | -98.27% | 0.00% | 0.00x | 1.52x | €-8.84 Million |
| 2023 | 0.00% | -2152.31% | 0.11x | 0.00x | €-13.90 Million |
| 2024 | 0.00% | -1095.66% | 0.11x | 0.00x | €-5.55 Million |
| 2025 | 0.00% | 0.00% | 0.00x | 0.00x | €-7.77 Million |
Industry Comparison
This section compares Amoeba SA's net assets metrics with peer companies in the Agricultural Inputs industry.
Industry Context
- Industry: Agricultural Inputs
- Average net assets among peers: $23,444,446
- Average return on equity (ROE) among peers: 18.58%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Amoeba SA (ALMIB) | €-5.36 Million | -26.07% | N/A | $45.47 Million |
| Florentaise SA (ALFLO) | $11.58 Million | 21.90% | 4.20x | $4.95 Million |
| Graines Voltz S.A (GRVO) | $35.31 Million | 15.26% | 0.66x | $25.76 Million |
About Amoeba SA
Amoéba S.A. develops biological products and services for the treatment of microbiological risk in the sectors of water, health, and plant protection in France. The company has developed technology to treat water, surfaces, and chronic wounds that uses the natural biocidal capacity of the living amoeba Willaertia magna C2c Maky; and agriculture biocontrol technology for the treatment of phytopath… Read more